Gene: NTMT1
Official Full Name: N-terminal Xaa-Pro-Lys N-methyltransferase 1provided by HGNC
Gene Summary: The METTL11A gene encodes an N-terminal methyltransferase for the RAN (MIM 601179) guanine nucleotide exchange factor regulator of chromosome condensation 1 (RCC1; MIM 179710). METTL11A enzyme alpha-N-methylates other protein targets such as SET (MIM 600960) and RB (MIM 180200).[supplied by OMIM, Nov 2010]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO06440 | NTMT1 Knockout cell line (HeLa) | Human | NTMT1 | 1:3~1:6 | Negative | Online Inquiry |
KO06441 | NTMT1 Knockout cell line (HCT 116) | Human | NTMT1 | 1:2~1:4 | Negative | Online Inquiry |
KO06442 | NTMT1 Knockout cell line (HEK293) | Human | NTMT1 | 1:3~1:6 | Negative | Online Inquiry |
KO06443 | NTMT1 Knockout cell line (A549) | Human | NTMT1 | 1:3~1:4 | Negative | Online Inquiry |
NTMT1 Gene Knockout Cell Lines represent a pivotal advancement in genetic research, designed to facilitate in-depth studies involving the NTMT1 (N-terminal methyltransferase 1) gene. These cell lines have been meticulously engineered to exhibit a complete loss of function of the NTMT1 gene, enabling researchers to explore its role in cellular processes, signaling pathways, and disease mechanisms. The NTMT1 enzyme is implicated in the methylation of N-terminal residues of proteins, which affects protein stability, localization, and function. By employing these knockout cell lines, scientists can discern the biochemical and physiological implications of NTMT1 loss, providing insights critical to understanding various pathologies, including cancer and neurodegenerative disorders.
The unique mechanism of these cell lines allows for straightforward comparisons between wild-type and knockout phenotypes, ensuring that changes observed can be attributed directly to the absence of the NTMT1 gene. This model can significantly advance research in epigenetics and protein regulation, a field that has garnered significant interest owing to its implications in therapeutic development.
Distinct from conventional cell lines, NTMT1 Gene Knockout Cell Lines offer significant advantages, including enhanced specificity in gene function elucidation, a reduced background of genetic variability, and compatibility with various assays, such as CRISPR-based gene editing and protein interaction studies. Researchers benefit from reliable and reproducible results in experimental setups, leading to more efficient research outputs.
For clinicians and researchers alike, the ability to probe the cellular consequences of gene knockout using these specialized cell lines opens avenues to innovative therapeutic strategies. By understanding the precise roles of NTMT1, it may be possible to identify novel intervention points in diseases associated with aberrant protein methylation.
Our company prides itself on delivering high-quality biological products developed through rigorous research protocols and advanced biotechnological processes. We are committed to empowering the scientific community with tools that enhance understanding and drive discovery in the field of molecular biology.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.